DK3273951T3 - Sammensætninger og fremgangsmåder til behandling af psoriasis - Google Patents
Sammensætninger og fremgangsmåder til behandling af psoriasis Download PDFInfo
- Publication number
- DK3273951T3 DK3273951T3 DK16773885.5T DK16773885T DK3273951T3 DK 3273951 T3 DK3273951 T3 DK 3273951T3 DK 16773885 T DK16773885 T DK 16773885T DK 3273951 T3 DK3273951 T3 DK 3273951T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- methods
- treating psoriasis
- psoriasis
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562139619P | 2015-03-27 | 2015-03-27 | |
| PCT/US2016/024392 WO2016160635A1 (en) | 2015-03-27 | 2016-03-27 | Compositions and methods for treating psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3273951T3 true DK3273951T3 (da) | 2020-11-02 |
Family
ID=56973828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16773885.5T DK3273951T3 (da) | 2015-03-27 | 2016-03-27 | Sammensætninger og fremgangsmåder til behandling af psoriasis |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9636321B2 (da) |
| EP (1) | EP3273951B1 (da) |
| DK (1) | DK3273951T3 (da) |
| ES (1) | ES2826825T3 (da) |
| WO (1) | WO2016160635A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10597402B2 (en) | 2015-03-27 | 2020-03-24 | Sytheon Limited | Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases |
| GB2560769B (en) * | 2017-03-24 | 2020-04-08 | Solvotrin Therapeutics Ltd | Compounds and compositions for use in treating psoriasis |
| AU2019262021A1 (en) * | 2018-05-02 | 2020-11-12 | Symbionyx Pharmaceuticals, Inc. | Methods and compositions for the treatment of multiple sclerosis |
| IT202200009791A1 (it) * | 2022-05-12 | 2023-11-12 | Innbiotec Pharma S R L | Composizione farmaceutica a base di glutatione e oleuropeina per l’uso nel trattamento della psoriasi |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB613444A (en) | 1946-01-17 | 1948-11-29 | John George Mackay Bremner | Improvements in and relating to the production of heterocyclic compounds |
| US4297290A (en) | 1980-07-17 | 1981-10-27 | Ici Americas Inc. | Process for preparing sorbitan esters |
| DE3111093A1 (de) | 1981-03-20 | 1982-10-07 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von gegebenenfalls zellfoermigen polyurethankunststoffen unter verwendung von diolen der dianhydro-hexit-reihe |
| DE3119553A1 (de) | 1981-05-16 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | "verfahren zur herstellung von carbonsaeureestern von anhydrohexiten" |
| DE3248548A1 (de) | 1982-12-29 | 1984-07-05 | Heinrich Mack Nachf., 7918 Illertissen | Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| JPS59175408A (ja) | 1983-03-23 | 1984-10-04 | Nippon Saafuakutanto Kogyo Kk | 化粧料 |
| US4627976A (en) | 1984-12-21 | 1986-12-09 | Ici Americas Inc. | Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation |
| CH664150A5 (de) * | 1985-01-15 | 1988-02-15 | Peter Paul Prof Dr Speiser | Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen. |
| DE3521809A1 (de) | 1985-06-19 | 1987-01-02 | Ruetgerswerke Ag | Verfahren zur herstellung von 2,5-dialkyl-1,4 |
| DE19721099C2 (de) | 1997-05-20 | 1999-12-02 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten |
| DE19723732B4 (de) | 1997-06-06 | 2006-04-20 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Monocacylestern des Isosorbids und ihre Verwendung |
| ES2194446T3 (es) | 1998-03-04 | 2003-11-16 | Ato Bv | Derivados de bibiclooctano utilizados como plastificantes. |
| DE19814358C2 (de) | 1998-03-31 | 2002-01-17 | Fumapharm Ag Muri | Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn |
| DE19839566C2 (de) | 1998-08-31 | 2002-01-17 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten in der Transplantationsmedizin |
| DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| US6524623B1 (en) | 1999-11-12 | 2003-02-25 | Milton Hodosh | Therapeutic compositions and methods of use thereof |
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| NL1015119C2 (nl) | 2000-05-04 | 2001-11-06 | Inst Agrotechnologisch Onderzoek Ato Dlo | Verbeterde synthese van anhydroglycitol-esters met verbeterde kleur. |
| US6433024B1 (en) | 2000-05-08 | 2002-08-13 | Karl F. Popp | Topical anti-acne composition |
| JP2004523511A (ja) | 2001-01-12 | 2004-08-05 | フーマファーム アーゲー | フマル酸アミド類 |
| MXPA06002657A (es) | 2003-09-09 | 2006-06-05 | Fumapharm Ag | Uso de derivados de acido fumarico para el tratamiento de insuficiencia cardiaca y asma. |
| FR2883877B1 (fr) | 2005-04-01 | 2008-10-10 | Roquette Freres | Procede de preparation de compositions de diester(s) de dianhydrohexitol |
| TWI312687B (en) | 2005-04-21 | 2009-08-01 | Kao Corporatio | Skin lotion and wrinkle improving agent |
| EP2186819A1 (en) | 2005-07-07 | 2010-05-19 | Aditech Pharma AG | Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use |
| KR101071516B1 (ko) | 2006-05-05 | 2011-10-10 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 2가 ｓｍａｃ 모방체 및 그의 용도 |
| PL2137537T3 (pl) | 2007-02-08 | 2013-10-31 | Biogen Ma Inc | Kompozycje i zastosowania do leczenia stwardnienia rozsianego |
| DE102007028702A1 (de) | 2007-06-21 | 2008-12-24 | Evonik Oxeno Gmbh | Verfahren zur Herstellung von Dianhydrohexitol-Diestern |
| WO2009155020A2 (en) | 2008-05-28 | 2009-12-23 | Archer Daniels Midland Company | Production of 5-membered and 6-membered cyclic esters of polyols |
| EP2174641A1 (de) | 2008-10-09 | 2010-04-14 | Cognis IP Management GmbH | Ölkörpermischungen, enthaltend Derivate des Isosorbids |
| EP2239315A1 (en) | 2009-04-09 | 2010-10-13 | Cognis IP Management GmbH | Isosorbide monoesters and their use in household applications |
| US8496917B2 (en) | 2009-11-13 | 2013-07-30 | Sytheon Ltd | Compositions and methods for improving skin appearance |
| US20140308224A1 (en) | 2011-08-04 | 2014-10-16 | Clariant International Ltd. | Cosmetic, dermatological or pharmaceutical compositions comprising isosorbide diesters and uv filters |
| CN103747680B (zh) * | 2011-08-04 | 2016-01-06 | 克拉里安特国际有限公司 | 包含异山梨醇单酯和异山梨醇二酯的组合物 |
| JP6027112B2 (ja) | 2011-08-04 | 2016-11-16 | クラリアント・インターナシヨナル・リミテツド | 抗菌作用物質としてのイソソルビドモノエステルの使用 |
| WO2013066461A2 (en) * | 2011-08-10 | 2013-05-10 | Palmese Giuseppe R | Renewable bio-based (meth) acrylated monomers as vinyl ester cross-linkers |
| ES2719262T3 (es) | 2011-09-19 | 2019-07-09 | Basf Se | Uso de monoésteres alquílicos de isosorbida como mejoradores de espuma en preparaciones cosméticas acuosas |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
-
2016
- 2016-03-27 WO PCT/US2016/024392 patent/WO2016160635A1/en active Application Filing
- 2016-03-27 EP EP16773885.5A patent/EP3273951B1/en active Active
- 2016-03-27 US US15/081,898 patent/US9636321B2/en active Active
- 2016-03-27 ES ES16773885T patent/ES2826825T3/es active Active
- 2016-03-27 DK DK16773885.5T patent/DK3273951T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016160635A1 (en) | 2016-10-06 |
| EP3273951A1 (en) | 2018-01-31 |
| US20160279092A1 (en) | 2016-09-29 |
| US9636321B2 (en) | 2017-05-02 |
| EP3273951A4 (en) | 2018-09-12 |
| EP3273951B1 (en) | 2020-07-29 |
| ES2826825T3 (es) | 2021-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3206493T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3134130T3 (da) | Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3250210T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
| DK3212226T3 (da) | Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser | |
| DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
| DK3288581T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK3888658T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3245225T3 (da) | Sammensætninger og fremgangsmåder til behandling og detektering af cancere | |
| DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
| DK3206497T3 (da) | Sammensætninger og fremgangsmåder til behandling af meibomsk kirtel-dysfunktion | |
| DK3137605T3 (da) | Sammensætninger og fremgangsmåder til modulering af angiopoietin-lignende-3-ekspression | |
| DK3119797T3 (da) | Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose | |
| DK3377516T3 (da) | Sammensætning til behandling af cancer | |
| DK3125927T3 (da) | Fremgangsmåder og sammensætninger til immunmodulering | |
| DK3092256T3 (da) | Forbindelser og sammensætninger til immunterapi | |
| DK3200815T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK2994533T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
| DK3261726T3 (da) | Sammensætning til behandling af acne | |
| DK3371313T3 (da) | Fremgangsmåder og sammensætninger til forbedret plantetransformation | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3110446T3 (da) | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme |